The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Clinical Trial (CTMS)-Global Market Insights and Sales Trends 2025
Synopsis
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial (CTMS) market size is expected to reach US$ 62370 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trial (CTMS) in various end use industries. The expanding demands from the Pharma & Biopharmaceutical Companies, Clinical Research Organizations and Others,, are propelling Clinical Trial (CTMS) market. Enterprise CTMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Site CTMS segment is estimated at % CAGR for the next seven-year period.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trial (CTMS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trial (CTMS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trial (CTMS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trial (CTMS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trial (CTMS) covered in this report include Oracle, Medidata Solutions, PAREXEL, IBM, ERT, Bioclinica, Forte Research Systems, Veeva Systems and MasterControl, etc.
The global Clinical Trial (CTMS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Oracle
Medidata Solutions
PAREXEL
IBM
ERT
Bioclinica
Forte Research Systems
Veeva Systems
MasterControl
MedNet Solutions
DSG
Bio-Optronics
DATATRAK
DZS Software Solutions
ArisGlobal
Global Clinical Trial (CTMS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trial (CTMS) market, Segment by Type:
Enterprise CTMS
Site CTMS
Global Clinical Trial (CTMS) market, by Application
Pharma & Biopharmaceutical Companies
Clinical Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trial (CTMS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial (CTMS) market size is expected to reach US$ 62370 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trial (CTMS) in various end use industries. The expanding demands from the Pharma & Biopharmaceutical Companies, Clinical Research Organizations and Others,, are propelling Clinical Trial (CTMS) market. Enterprise CTMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Site CTMS segment is estimated at % CAGR for the next seven-year period.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trial (CTMS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trial (CTMS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trial (CTMS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trial (CTMS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trial (CTMS) covered in this report include Oracle, Medidata Solutions, PAREXEL, IBM, ERT, Bioclinica, Forte Research Systems, Veeva Systems and MasterControl, etc.
The global Clinical Trial (CTMS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Oracle
Medidata Solutions
PAREXEL
IBM
ERT
Bioclinica
Forte Research Systems
Veeva Systems
MasterControl
MedNet Solutions
DSG
Bio-Optronics
DATATRAK
DZS Software Solutions
ArisGlobal
Global Clinical Trial (CTMS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trial (CTMS) market, Segment by Type:
Enterprise CTMS
Site CTMS
Global Clinical Trial (CTMS) market, by Application
Pharma & Biopharmaceutical Companies
Clinical Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trial (CTMS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Clinical Trial (CTMS)
1.1 Clinical Trial (CTMS) Market Overview
1.1.1 Clinical Trial (CTMS) Product Scope
1.1.2 Clinical Trial (CTMS) Market Status and Outlook
1.2 Global Clinical Trial (CTMS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Clinical Trial (CTMS) Market Size by Region (2018-2029)
1.4 Global Clinical Trial (CTMS) Historic Market Size by Region (2018-2023)
1.5 Global Clinical Trial (CTMS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Clinical Trial (CTMS) Market Size (2018-2029)
1.6.1 North America Clinical Trial (CTMS) Market Size (2018-2029)
1.6.2 Europe Clinical Trial (CTMS) Market Size (2018-2029)
1.6.3 Asia-Pacific Clinical Trial (CTMS) Market Size (2018-2029)
1.6.4 Latin America Clinical Trial (CTMS) Market Size (2018-2029)
1.6.5 Middle East & Africa Clinical Trial (CTMS) Market Size (2018-2029)
2 Clinical Trial (CTMS) Market by Type
2.1 Introduction
2.1.1 Enterprise CTMS
2.1.2 Site CTMS
2.2 Global Clinical Trial (CTMS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Clinical Trial (CTMS) Historic Market Size by Type (2018-2023)
2.2.2 Global Clinical Trial (CTMS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Clinical Trial (CTMS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Clinical Trial (CTMS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Clinical Trial (CTMS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Clinical Trial (CTMS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Clinical Trial (CTMS) Revenue Breakdown by Type (2018-2029)
3 Clinical Trial (CTMS) Market Overview by Application
3.1 Introduction
3.1.1 Pharma & Biopharmaceutical Companies
3.1.2 Clinical Research Organizations
3.1.3 Others
3.2 Global Clinical Trial (CTMS) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Clinical Trial (CTMS) Historic Market Size by Application (2018-2023)
3.2.2 Global Clinical Trial (CTMS) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Clinical Trial (CTMS) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Clinical Trial (CTMS) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Clinical Trial (CTMS) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Clinical Trial (CTMS) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Clinical Trial (CTMS) Revenue Breakdown by Application (2018-2029)
4 Clinical Trial (CTMS) Competition Analysis by Players
4.1 Global Clinical Trial (CTMS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Trial (CTMS) as of 2022)
4.3 Date of Key Players Enter into Clinical Trial (CTMS) Market
4.4 Global Top Players Clinical Trial (CTMS) Headquarters and Area Served
4.5 Key Players Clinical Trial (CTMS) Product Solution and Service
4.6 Competitive Status
4.6.1 Clinical Trial (CTMS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Oracle
5.1.1 Oracle Profile
5.1.2 Oracle Main Business
5.1.3 Oracle Clinical Trial (CTMS) Products, Services and Solutions
5.1.4 Oracle Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.1.5 Oracle Recent Developments
5.2 Medidata Solutions
5.2.1 Medidata Solutions Profile
5.2.2 Medidata Solutions Main Business
5.2.3 Medidata Solutions Clinical Trial (CTMS) Products, Services and Solutions
5.2.4 Medidata Solutions Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.2.5 Medidata Solutions Recent Developments
5.3 PAREXEL
5.3.1 PAREXEL Profile
5.3.2 PAREXEL Main Business
5.3.3 PAREXEL Clinical Trial (CTMS) Products, Services and Solutions
5.3.4 PAREXEL Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.3.5 IBM Recent Developments
5.4 IBM
5.4.1 IBM Profile
5.4.2 IBM Main Business
5.4.3 IBM Clinical Trial (CTMS) Products, Services and Solutions
5.4.4 IBM Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.4.5 IBM Recent Developments
5.5 ERT
5.5.1 ERT Profile
5.5.2 ERT Main Business
5.5.3 ERT Clinical Trial (CTMS) Products, Services and Solutions
5.5.4 ERT Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.5.5 ERT Recent Developments
5.6 Bioclinica
5.6.1 Bioclinica Profile
5.6.2 Bioclinica Main Business
5.6.3 Bioclinica Clinical Trial (CTMS) Products, Services and Solutions
5.6.4 Bioclinica Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.6.5 Bioclinica Recent Developments
5.7 Forte Research Systems
5.7.1 Forte Research Systems Profile
5.7.2 Forte Research Systems Main Business
5.7.3 Forte Research Systems Clinical Trial (CTMS) Products, Services and Solutions
5.7.4 Forte Research Systems Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.7.5 Forte Research Systems Recent Developments
5.8 Veeva Systems
5.8.1 Veeva Systems Profile
5.8.2 Veeva Systems Main Business
5.8.3 Veeva Systems Clinical Trial (CTMS) Products, Services and Solutions
5.8.4 Veeva Systems Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.8.5 Veeva Systems Recent Developments
5.9 MasterControl
5.9.1 MasterControl Profile
5.9.2 MasterControl Main Business
5.9.3 MasterControl Clinical Trial (CTMS) Products, Services and Solutions
5.9.4 MasterControl Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.9.5 MasterControl Recent Developments
5.10 MedNet Solutions
5.10.1 MedNet Solutions Profile
5.10.2 MedNet Solutions Main Business
5.10.3 MedNet Solutions Clinical Trial (CTMS) Products, Services and Solutions
5.10.4 MedNet Solutions Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.10.5 MedNet Solutions Recent Developments
5.11 DSG
5.11.1 DSG Profile
5.11.2 DSG Main Business
5.11.3 DSG Clinical Trial (CTMS) Products, Services and Solutions
5.11.4 DSG Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.11.5 DSG Recent Developments
5.12 Bio-Optronics
5.12.1 Bio-Optronics Profile
5.12.2 Bio-Optronics Main Business
5.12.3 Bio-Optronics Clinical Trial (CTMS) Products, Services and Solutions
5.12.4 Bio-Optronics Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.12.5 Bio-Optronics Recent Developments
5.13 DATATRAK
5.13.1 DATATRAK Profile
5.13.2 DATATRAK Main Business
5.13.3 DATATRAK Clinical Trial (CTMS) Products, Services and Solutions
5.13.4 DATATRAK Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.13.5 DATATRAK Recent Developments
5.14 DZS Software Solutions
5.14.1 DZS Software Solutions Profile
5.14.2 DZS Software Solutions Main Business
5.14.3 DZS Software Solutions Clinical Trial (CTMS) Products, Services and Solutions
5.14.4 DZS Software Solutions Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.14.5 DZS Software Solutions Recent Developments
5.15 ArisGlobal
5.15.1 ArisGlobal Profile
5.15.2 ArisGlobal Main Business
5.15.3 ArisGlobal Clinical Trial (CTMS) Products, Services and Solutions
5.15.4 ArisGlobal Clinical Trial (CTMS) Revenue (US$ Million) & (2018-2023)
5.15.5 ArisGlobal Recent Developments
6 North America
6.1 North America Clinical Trial (CTMS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Clinical Trial (CTMS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial (CTMS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Clinical Trial (CTMS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial (CTMS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Clinical Trial (CTMS) Market Dynamics
11.1 Clinical Trial (CTMS) Industry Trends
11.2 Clinical Trial (CTMS) Market Drivers
11.3 Clinical Trial (CTMS) Market Challenges
11.4 Clinical Trial (CTMS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
